Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-α-induced apoptosis in bladder cancer cells

Chinese Medical Journal

Volumn 120, Issue 9, 2007, Pages 755-760

  Gao, Xiao Dong ^a,b   Chen, Yi Rong ^b  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Phosphorothioate antisense oligodeoxynucleotide; Telomerase; Tumor necrosis factor ; Urinary bladder neoplasms

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; TELOMERASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG PURIFICATION; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34248640888     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200705010-00004     Document Type: Article

References (24)

1. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225: 951-960.
2. Hao ZM, Luo JY, Cheng J, Wang QY, Yang GX. Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of its gene. World J Gastroenterol 2003; 9: 104-107.
3. Harley CB. Telomerase is not an oncogene. Oncogene 2002; 21: 494-502.
4. Jiang YA, Luo HS, Zhang YY, Fan LF, Jiang CQ, Chen WJ, et al.Telomerase activity and cell apoptosis in colon cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide. World J Gastroenterol 2003; 9: 1981-1984.
5. Shay JW, Bacchetti S.A. Survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-791.
6. Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer 1997; 33: 781-786.
7. Helder MN, Jong S, Vries EG, Zee AG. Telomerase targeting in cancer treatment: new developments. Drug Resist Update 1999; 2: 104-115.
8. Stewart SA, Weinberg RA. Telomerase and human cancer genesis. Semin Cancer Biol 2000; 10: 399-406.
9. Yokoyama Y, Takahashi Y, Shinohara A, Wan X, Takahashi S, Niwa K, et al. The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Biochem Biophys Res 2001; 61: 3053-3061.
10. Chen W, Xiong X, Zhou H, Zhou Q. Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer. Chin Med J 2002; 115: 290-292.
11. Masutomi K, Possemato R. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. PNAS 2005; 102: 8222-8227.
12. Kondo S, Kondo Y, Li G. Targeted therapy of human malignant glioma in a mouse model by 205A antisense directed against telomerase RNA. Oncogene 1998; 16: 3323-3330.
13. He DM, Zhang Y. Inhibition of leukemia cell telomerase activity by antisense phosphorothioate oligodeoxynucleotide. Chin German J Clin Oncol 2002; 1: 104-106.
14. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-667.
15. Yang Y, Chen Y, Zhang C, Huang H, Weissman SM. Nuclear localization of hTERT protein is associated with telomerase function. Exp Cell Res 2002; 277: 201-209.
16. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiucp A, et al. The RNA component of human telomerase. Science 1995; 269: 1236-1241.
17. Dudognon C, Pendino F, Hillion J, Saumet A, Lanotte M, Segal-Bendirdjian E, et al. Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance. Oncogene 2004; 23: 7469-7474.
18. Nakayama J, Tahara H, Tahara E. Telomerase activation by hTERT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18: 65-68.
19. Yu WQ, Sun BZ, Chen Z. Effect of antisense oligodeoxynucleotides to PML-RARa fusion gene on acute promyelocytic leukemia cell line NB4. Chin J Hematol (Chin) 1998; 19: 227-230.
20. Old LJ. Tumor necrosis factor (TNF). Science 1985; 18: 230-630.
21. Idriss HT, Naismith JH. TNFα and the TNF receptor super family: structure-function relationship(s). Microsc Res Tech 2000; 50: 184-195.
22. Zhu XY, Zhang QX. Cell apoptosis. In: Zhang QX, He LY, Li PF, eds. Molecular biology of medicine. Zhengzhou: Zhengzhou University Press; 2003: 105-112.
23. Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Cowell JK, et al. Antisense telomerase treatment: induction two distinct pathways, apoptosis and differentiation. FASEB J 1998; 12: 801-811.
24. Zhang X, Ma V, Zhou W. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 1999; 13: 2388-2399.